Wave Life Sciences Ltd. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Wave Life Sciences Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Wave Life Sciences Ltd. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.88M, a 4.76% increase year-over-year.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $9.8M, a 43% decline from 2022.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $17.2M, a 4.8% increase from 2021.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2021 was $16.4M, a 14.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.8M -$7.4M -43% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $17.2M +$787K +4.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $16.4M +$2.11M +14.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $14.3M -$5.21M -26.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $19.5M +$3.91M +25.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $15.6M +$3.45M +28.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $12.1M +$5.3M +77.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $6.85M +$2.82M +70.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $4.02M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.